Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 16/20 | 0.49 |
| ▸ | BRAF | P15056 | 16/20 | 0.49 |
| ▸ | NMT1 | P30419 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.41 |
| ▸ | CDC42BPB | Q9Y5S2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20008475 | 0.78 | RAF1 (0.39) | RAF1BRAFROCK2ROCK1CDC42BPB | |
| SCHEMBL20008242 | 0.77 | RAF1 (0.84) | RAF1BRAF | |
| SCHEMBL28531378 | 0.76 | GRIN2D (0.58) | NMT1HRH4ROCK2ROCK1CDC42BPB | |
| SCHEMBL20008786 | 0.76 | RAF1 (0.46) | RAF1BRAFROCK2ROCK1CDC42BPB | |
| SCHEMBL20008619 | 0.75 | RAF1 (0.84) | RAF1BRAF | |
| SCHEMBL4098509 | 0.75 | GRIN2D (0.60) | NMT1HRH4ROCK2ROCK1CDC42BPB | |
| SCHEMBL20008373 | 0.74 | RAF1 (0.46) | RAF1BRAF | |
| SCHEMBL20008216 | 0.74 | RAF1 (0.47) | RAF1BRAFROCK2ROCK1CDC42BPB | |
| SCHEMBL20008138 | 0.73 | RAF1 (0.87) | RAF1BRAF | |
| SCHEMBL20008259 | 0.73 | RAF1 (0.38) | RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3299367-A1 | BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS | Novartis AG (CH) | 2018-03-28 | — | — | EP | disclosed |